Barriers to excellent U.S. cancer care remain daunting as the number cancer
cases rises from 1.6 million to some 2.3 million in 2022, a non-profit group
A report by The Institute of Medicine, an independent, non-profit organization,
said the U.S. cancer care delivery system is in crisis due to a growing demand
for cancer care, increasing complexity of treatment, a shrinking workforce and
The IMO convened a committee of experts to examine the quality of U.S. cancer
care and to formulate recommendations for improvement. The report, "Delivering
High-Quality Cancer Care: Charting a New Course for a System in Crisis"
presented the committee's findings and recommendations.
All stakeholders -- including cancer care teams, patients, their families,
researchers, quality metrics developers, payers, the U.S. Department of Health
and Human Services, federal agencies and industries -- must re-evaluate their
current roles and responsibilities in cancer care and work together to develop a
higher quality cancer care delivery system, the report said.